Bipolar II compared with bipolar I disorder: baseline characteristics and treatment response to quetiapine in a pooled analysis of five placebo-controlled clinical trials of acute bipolar depression
Crossref DOI link: https://doi.org/10.1186/s12991-016-0096-0
Published Online: 2016-03-11
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Datto, Catherine
Pottorf, William J.
Feeley, Louisa
LaPorte, Scott
Liss, Charlie
Funding for this research was provided by:
AstraZeneca Pharmaceuticals